Variant report

Variant	rs4779843
Chromosome Location	chr15:31516712-31516713
allele	G/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr15:31505148..31511050-chr15:31511462..31517687,6	K562	blood:

Variant related genes	Relation type
ENSG00000259448	Chromatin interaction

Extended variants
information (count: 16 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:3)

rs_ID	r²[population]
rs4779844	1.00[CEU][hapmap];0.86[CHB][hapmap];0.80[JPT][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes];1.00[AMR][1000 genomes];0.94[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs7161875	0.99[AMR][1000 genomes];0.91[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs755563	0.99[AMR][1000 genomes];0.94[EUR][1000 genomes];0.93[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:13 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv531138	chr15:30653877-31609679	Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	96 gene(s)	inside rSNPs	diseases
2	nsv903831	chr15:30986051-31723279	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	84 gene(s)	inside rSNPs	diseases
3	nsv1054147	chr15:31014507-31972706	Weak transcription Enhancers Flanking Active TSS Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
4	nsv542306	chr15:31014507-31972706	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
5	nsv1036018	chr15:31140415-31544888	Enhancers Flanking Active TSS Active TSS Genic enhancers Strong transcription Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	58 gene(s)	inside rSNPs	diseases
6	nsv1052722	chr15:31261834-31609680	Flanking Active TSS Weak transcription Enhancers Active TSS Strong transcription Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	52 gene(s)	inside rSNPs	diseases
7	nsv542315	chr15:31261834-31609680	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Genic enhancers ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	52 gene(s)	inside rSNPs	diseases
8	nsv932896	chr15:31292475-31730445	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	59 gene(s)	inside rSNPs	diseases
9	nsv903838	chr15:31452911-31672128	Strong transcription Flanking Active TSS Enhancers Genic enhancers Weak transcription Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	33 gene(s)	inside rSNPs	diseases
10	esv1815415	chr15:31483843-31697213	Genic enhancers Flanking Active TSS Active TSS Enhancers Weak transcription Strong transcription Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
11	nsv903839	chr15:31495113-31576677	Flanking Active TSS Enhancers Active TSS Weak transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	21 gene(s)	inside rSNPs	diseases
12	esv34100	chr15:31496514-31792591	Active TSS Enhancers ZNF genes & repeats Weak transcription Genic enhancers Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	46 gene(s)	inside rSNPs	diseases
13	nsv977067	chr15:31509197-31523063	Genic enhancers Enhancers Bivalent Enhancer ZNF genes & repeats Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:73 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:31509600-31520600	Weak transcription	HepG2	liver
2	chr15:31510800-31520600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
3	chr15:31513200-31518000	Enhancers	Fetal Thymus	thymus
4	chr15:31513800-31517400	Enhancers	Primary hematopoietic stem cells short term culture	blood
5	chr15:31514000-31516800	Enhancers	Primary hematopoietic stem cells	blood
6	chr15:31514000-31517600	Enhancers	Primary B cells from cord blood	blood
7	chr15:31514200-31516800	Enhancers	Sigmoid Colon	Sigmoid Colon
8	chr15:31514200-31516800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
9	chr15:31514200-31517000	Enhancers	Esophagus	oesophagus
10	chr15:31514200-31517000	Enhancers	Spleen	Spleen
11	chr15:31514200-31517200	Enhancers	HUES48 Cell Line	embryonic stem cell
12	chr15:31514200-31517400	Enhancers	Primary T helper cells fromperipheralblood	blood
13	chr15:31514200-31517800	Enhancers	Stomach Mucosa	stomach
14	chr15:31514400-31517000	Enhancers	Primary T cells from cord blood	blood
15	chr15:31514600-31521400	Weak transcription	A549	lung
16	chr15:31514800-31516800	Enhancers	Lung	lung
17	chr15:31515000-31516800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr15:31515000-31516800	Enhancers	Rectal Mucosa Donor 31	rectum
19	chr15:31515000-31517800	Bivalent Enhancer	Fetal Muscle Leg	muscle
20	chr15:31515000-31521200	Weak transcription	Hela-S3	cervix
21	chr15:31515200-31516800	Enhancers	Right Ventricle	heart
22	chr15:31515400-31516800	Enhancers	Right Atrium	heart
23	chr15:31515400-31517800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
24	chr15:31515600-31519800	Weak transcription	Gastric	stomach
25	chr15:31515600-31520000	Weak transcription	Thymus	Thymus
26	chr15:31515800-31516800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
27	chr15:31515800-31517000	Enhancers	Primary B cells from peripheral blood	blood
28	chr15:31515800-31517000	Flanking Active TSS	Brain Hippocampus Middle	brain
29	chr15:31515800-31517000	Weak transcription	Duodenum Smooth Muscle	Duodenum
30	chr15:31515800-31517200	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
31	chr15:31515800-31521200	Weak transcription	Fetal Intestine Small	intestine
32	chr15:31516000-31516800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
33	chr15:31516000-31516800	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
34	chr15:31516000-31516800	Flanking Active TSS	HSMMtube	muscle
35	chr15:31516000-31517200	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr15:31516000-31517200	Weak transcription	Primary T helper cells PMA-I stimulated	--
37	chr15:31516200-31516800	Bivalent Enhancer	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr15:31516200-31516800	Flanking Active TSS	Brain Anterior Caudate	brain
39	chr15:31516200-31516800	Flanking Active TSS	Brain Substantia Nigra	brain
40	chr15:31516200-31516800	Enhancers	Pancreas	Pancrea
41	chr15:31516200-31517000	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
42	chr15:31516200-31517200	Bivalent Enhancer	Fetal Stomach	stomach
43	chr15:31516200-31522000	Enhancers	Primary monocytes fromperipheralblood	blood
44	chr15:31516400-31516800	Bivalent Enhancer	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
45	chr15:31516400-31516800	Bivalent Enhancer	Placenta	Placenta
46	chr15:31516400-31516800	Transcr. at gene 5' and 3'	GM12878-XiMat	blood
47	chr15:31516400-31516800	Bivalent Enhancer	HUVEC	blood vessel
48	chr15:31516400-31516800	Enhancers	NHDF-Ad	bronchial
49	chr15:31516400-31517000	Flanking Active TSS	HSMM	muscle
50	chr15:31516400-31517200	Enhancers	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links